Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Transplantation. 2016 Dec;100(12):2729–2734. doi: 10.1097/TP.0000000000001059

Table 5.

a. Univariate analysis of proposed factors associated with postoperative RHF
Variable Unadjusted
Odds Ratio
95% Confidence Interval p-value
Donor: Weight (kg) 1.4 0.8–2.6 0.24
Donor: Cause of death 1.1 0.7–1.6 0.68
Donor: Low-dose dopamine pre-treatment 0.3 0.1–0.8 0.02
Donor: High-dose dopamine pre-treatment 0.4 0.1–1.4 0.16
Donor: Other inotrope pre-treatment 1.8 0.6–4.9 0.27
Donor: Thyroxine pre-treatment 0.9 0.4–2.0 0.88
Donor: Downtime (y/n) 0.8 0.4–1.9 0.74
Donor: Abnormal echocardiogram 0.7 0.2–3.6 0.73
Recipient: Admission diagnosis 1.1 0.7–1.9 0.61
Recipient: Ventilator support, pre-operative 0.6 0.2–2.1 0.43
Recipient: VAD placement, pre-operative 0.6 0.2–2.3 0.48
Recipient: ECMO, pre-operative 1.6 0.4–6.3 0.50
Recipient: High-dose/Multiple Inotropes 1.8 0.8–4.3 0.17
Recipient: Status 1A, prior to transplant 1.8 0.6–5.4 0.32
Recipient: PVRi, pre-operative 1.2 1.1–1.4 0.006
Graft cold ischemic time (mins) 1.0 0.9–1.1 0.55
Cardiopulmonary bypass time (mins) 1.0 0.9–1.1 0.40
b. Multivaraible model of risk factors associated with postoperative RHF
Variable Adjusted
Odds Ratio
95% Confidence Interval p-value
Donor: Low-dose dopamine 0.16 0.04–0.78 0.02
Donor: High-dose dopamine 0.31 0.06–1.6 0.16
Recipient: Elevated Pre-operative PVRi (>6 WU × m2) 4.0 1.4–11.9 0.01
Graft cold ischemic time (mins) 0.99 0.98–1.0 0.40
Cardiopulmonary bypass time (mins) 1.0 0.99–1.01 0.61
c: Reduced multivaraible model of risk factors associated with postoperative RHF
Variable Adjusted
Odds Ratio
95% Confidence Interval p-value
Donor: Low-dose dopamine 0.14 0.03–0.69 0.02
Donor: High-dose dopamine 0.31 0.06–1.5 0.15
Recipient: Elevated Pre-operative PVRi (>6 WU × m2) 5.1 1.8–14.5 0.002